Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: CNS, Inc.

This article was originally published in The Tan Sheet

Executive Summary

CNS, Inc.: Gains FDA clearance to market its Breathe Right nasal strip "for the reduction or elimination of snoring," the company announces Nov.8. The clearance allows the company to expand its present claim for the product, cleared in 1993, that it "improves nasal breathing by reducing nasal airway resistance." CNS says that recent studies have shown that "75% of participants snored less often and less loudly when wearing the Breathe Right strip." The Minneapolis-based firm estimates that there are 40 mil. chronic snorers in the U.S...
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084487

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel